FP7

Innovative Medicines Initiative launches novel trial design in Alzheimer’s trial

Friday, December 13, 2013

The Innovative Medicines Initiative (IMI) is launching a major new project that will pioneer a novel, more flexible approach to clinical trials of drugs designed to prevent Alzheimer’s disease. The $72.7 million project, which will see several biotechnology and pharmaceutical companies working closely together, will aim to speed up drug development and patient access to the latest treatments.

[Read More]